U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06801288) titled 'Diagnostic Role of Renal Biopsy in Patients With Fabry Disease' on Dec. 30, 2024.
Brief Summary: This is a retrospective, single-centre, non-pharmacological observational study carried out for scientific and health protection purposes. It provides for the systematic collection of information from the medical records of patients with a genetic diagnosis of Fabry Disease referred to the single centre of Renal Genetic Diseases of the IRCCS Azienda Ospedaliero-Universitaria di Bologna.
These patients were considered eligible for the biopsy procedure if:
* presence of a clinical picture compatible with a classical phenotype
* presence...